Sector Update: Health Care Stocks Advance Late Afternoon
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 29 2024
0mins
Source: NASDAQ.COM
Health Care Stock Performance: Health care stocks experienced gains, with the NYSE Health Care Index and Health Care Select Sector SPDR Fund (XLV) both increasing by 0.3%, while the iShares Biotechnology ETF (IBB) rose by 0.7%.
Corporate Highlights: XORTX Therapeutics shares surged 131% due to promising research on kidney disease treatment, Cooper's shares jumped nearly 12% after strong earnings, and Adaptive Biotechnologies gained 3.6% following EU certification for its test.
Analyst Views on BAM
Wall Street analysts forecast BAM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BAM is 65.16 USD with a low forecast of 57.85 USD and a high forecast of 75.80 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
3 Buy
6 Hold
1 Sell
Hold
Current: 52.040
Low
57.85
Averages
65.16
High
75.80
Current: 52.040
Low
57.85
Averages
65.16
High
75.80
About BAM
Brookfield Asset Management Ltd. is a global alternative asset manager. The Company invests client capital for the long-term with a focus on real assets and essential service businesses that form the backbone of the global economy. It offers a range of alternative investment products to investors around the world including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies and private wealth investors. Its products have three categories, which include long-term private funds, permanent capital vehicles and perpetual strategies, and liquid strategies. These are invested across five principal strategies: renewable power and transition, infrastructure, real estate, private equity, and credit.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
